Kujoo launched non-prescription anti-obesity drug.

Published: 2001-10-23 06:56:00

Updated: 2001-10-23 06:56:00

Amid soaring social interests in the anti-obesity drug Kujoo pharmaceutical company announced on Oct. 18 that they would launch a non-prescription anti-obesity drug named "Exolise" next month,

Unlike Xenical and Reductil, all prescription anti-obesity drugs, Exolise was registered as a non-p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK